Onchocerciasis in West Africa after 2002: a challenge to take up.
Initially planned for a 20 year life time, the Onchocerciasis Control Programme in West Africa (OCP) will have finally continued its activities for nearly three decades (vector control alone from 1975 to 1989, then vector control and/or therapeutic treatment until 2002). Although onchocerciasis is no longer a problem of public health importance nor an obstacle to socio-economic development in the OCP area, the control of this filariasis is not over because OCP never aimed at eradication, neither of the parasite (Onchocerca volvulus), nor of its vector (Simulium damnosum s.l.). In 2003, the eleven Participating countries of OCP will take over the responsibility of carrying out the residual activities of monitoring and the control of this disease. This mission is of great importance because any recrudescence of the transmission could lead in the long run to the reappearance of the clinical signs of onchocerciasis, if not its most serious manifestations. For epidemiological and operational reasons, and given the disparity in national health policies and infrastructures, the capacities of the countries to take over the residual activities of monitoring and control of onchocerciasis are very unequal. Indeed, the interventions to be carried out are very different from one country to another and the process of integrating the residual activities into the national health systems is not taking place at the same pace. This inequality among the countries vis-a-vis the challenges to be met does not, however, prejudge the epidemiological situation after 2002 whose evolution will also depend on the effectiveness of the provisions made before that date by OCP, then after 2002, by the Regional Office for Africa of the World Health Organization which is currently setting up a sub-regional multidisease surveillance centre.
J M
JM
Hougard
L
L
Yameogo
B
B
Philippon
D000354:Africa, Western / Q000453:epidemiology; D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use; D015822:Eye Infections, Parasitic / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D005544:Forecasting; D006040:Goals; D006078:Government Programs / Q000458:organization & administration / Q000706:statistics & numerical data; D006801:Humans; D007300:Insect Control; D007303:Insect Vectors / Q000469:parasitology; D007391:International Cooperation; D007559:Ivermectin / Q000627:therapeutic use; D017181:Onchocerca volvulus / Q000502:physiology; D009855:Onchocerciasis / Q000453:epidemiology* / Q000517:prevention & control / Q000628:therapy; D011159:Population Surveillance; D015397:Program Evaluation; D012843:Simuliidae / Q000469:parasitology; D012876:Skin Diseases, Parasitic / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D014944:World Health Organization
D000871:Anthelmintics; D007559:Ivermectin